Among the myriad drugmakers laying out their plans for the future at this year’s J.P. Morgan Healthcare Conference, Takeda said it's laser-focused on six pipeline assets that could each reel in ...

Julie Kim is set to replace Christophe Weber as the new chief executive officer of Takeda Pharmaceutical Co., becoming the first woman to lead the more than 240-year-old Japanese drugmaker.

Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. East Asian Americans are ...

Tokyo, Jan. 30 (Jiji Press)--Japan's Takeda Pharmaceutical Co. said Thursday that its president and CEO, Christophe Weber, will step down at its general shareholders meeting in June 2026.

Takeda, a Japanese biopharmaceutical firm, on Wednesday said it would hire 750 deeptech professionals in calendar 2025 to be deployed at its newly set-up Innovation Capability Centre (ICC) in ...

The company has already hired 275 employees at the time of the announcement. During a press conference, Takeda executives said that Bengaluru was chosen for its rich talent pool and will host the ...

Clash rules everything around me. Rapper and actor Method Man, a member of the legendary hip-hop collective Wu-Tang Clan, was allegedly involved in an assault on a family friend at a Crunch ...

While 2024 was all about vintage watches and expensive alarm clocks, different status symbols are taking over in 2025. Home decor is now all about stained-glass lamps and $600 calendars.

Takeda Canada Inc. (Takeda) is pleased to announce that Héma-Québec has added HyQvia®– (normal immunoglobulin [human] 10% and recombinant human hyaluronidase solution for subcutaneous ...

Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's biggest drugmaker as the company upped its full-year profit outlook ...

Takeda has bolstered its near-term pipeline in rare haematological disorders by licensing rights to a polycythaemia vera (PV) treatment being developed by Protagonist Therapeutics. The Japanese ...

Takeda has officially taken over Shire in a deal that could re-establish the trend for mega mergers in big pharma. The merger was approved yesterday in a court hearing in Jersey, where Shire was ...